Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Rekambys
(rilpivirine)
Uses, side effects, dosage information & price range
About this medicine
REKAMBYS is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (HIV 1) infection in adults and adolescents (at least 12 years of age and weighing at least 35 kg) who are virologically suppressed (HIV-1 RNA < 50 copies/mL) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the non-nucleoside reverse transcriptase inhibitor (NNRTI) and integrase inhibitor (INI) class.
Common Brand Names for this Composition
The following popular commercial brand names contain rilpivirine as their active ingredient composition:
Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris
Viatris Limited
Eviplera
Gilead Sciences International Ltd
Juluca
ViiV Healthcare B.V.
Rekambys
Janssen-Cilag International NV
Edurant
Janssen-Cilag International N.V.
Odefsey
Gilead Sciences Ireland UC
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
rilpivirine
Category
Antivirals for systemic use
Manufacturer
Janssen-Cilag International NV
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.